AuntMinnie

JUNE 10, 2024

Emery has more than 30 years of experience in financial executive leadership in the pharmaceutical and medical device industries. Prior to that, he led financial executive teams at Plasma Surgical and Abbott Pharmaceuticals. He was previously CFO and chief operating officer (COO) at Tyber Medical.

Pharmaceutical 52

Pharmaceutical Medical Device Ultrasound Medical 52

Radiology Business

DECEMBER 18, 2023

Telix Pharmaceuticals recently submitted its license application to the FDA for the investigational positron emission tomography agent TLX250-CDx (Zircaix).

Pharmaceutical 107

Pharmaceutical Imaging IT 107

AuntMinnie

MAY 28, 2024

Telix Pharmaceuticals has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for a new prostate-specific membrane antigen (PSMA)-PET cold kit for prostate cancer imaging.

Pharmaceutical 96

Pharmaceutical Imaging 96

Radiology Business

FEBRUARY 27, 2024

Progenics Pharmaceuticals Inc. claims MIM stole its patents and used them to help entice GE HealthCare to buy the company in January.

Pharmaceutical 94

Pharmaceutical Radiology Healthcare Healthcare 94

Diagnostic Imaging

JULY 5, 2023

The prospective multicenter trial, which is slated to begin patient recruitment in late 2023, will reportedly assess the ability of 64Cu SAR-bisPSMA to diagnose prostate cancer within pelvic lymph nodes.

Pharmaceutical 58

Pharmaceutical Diagnose 58

Radiology Business

SEPTEMBER 20, 2023

Backers include societies representing radiologists and nuclear medicine professionals, device manufacturers, patient advocacy groups, and pharmaceutical companies.

Nuclear Medicine 101

Nuclear Medicine Pharmaceutical Diagnostic Imaging Diagnostic 101

Imaging Technology

AUGUST 29, 2023

Administration of the therapeutic dose took place as part of an ongoing Phase I/IIa theranostic clinical trial conducted by Clarity Pharmaceuticals to investigate the safety and efficacy of Cu-67 SARTATE in pediatric patients with high-risk neuroblastoma.

Pharmaceutical 72

Pharmaceutical Radiopharmaceuticals Clinic Medical 72

AuntMinnie

MAY 19, 2024

He will oversee Lantheus’ research and development organization, including research and pharmaceutical development, regulatory affairs, clinical development, medical affairs, and isotope strategy. He has spent more than two decades working for pharmaceutical companies such as Bayer, Bristol-Myers Squibb, Kyowa Kirin, and Pfizer.

Pharmaceutical 52

Pharmaceutical Medical Imaging Medical Clinic 52

MRI Network

MARCH 25, 2024

Big data has become a pillar in modern pharmaceutical practices. Pharmaceutical companies have also leveraged big data in third-party collaborations, resulting in more efficient product deployment and customer experiences. Industry experts predict the pharmaceutical analytical testing market could total an estimated USD 8.98

Pharmaceutical 59

Pharmaceutical Quality and Compliance Clinic Diagnostic 59

AuntMinnie

JUNE 2, 2024

Telix Pharmaceuticals has completed the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for its new PET agent, TLX250-CDx. TLX250-CDx (Zircaix) characterizes renal masses as clear cell renal cell carcinoma, the company said.

Pharmaceutical 52

Pharmaceutical IT 52

AuntMinnie

JANUARY 21, 2024

Bayer has appointed Nelson Ambrogio as its new head of radiology business in its pharmaceuticals division. Ambrogio will serve on Bayer's pharmaceuticals executive committee and be based in Berlin, Germany; he will report to Stefan Oelrich, who is a member of the company's board of management and president of its pharmaceuticals division.

Pharmaceutical 40

Pharmaceutical Radiology IT 40

AuntMinnie

DECEMBER 3, 2023

Telix Pharmaceuticals is highlighting that the first patient has been dosed with the company's TLX250-CDx (Zr-89 DFO-girentuximab) for clear cell renal cell carcinoma, the most common and aggressive form of kidney cancer.

Pharmaceutical 94

Pharmaceutical Medical IT Radiology 94

Open Medscience

JANUARY 12, 2024

Radiopharmaceuticals, combining radioactive and pharmaceutical elements, enable precise diagnosis and treatment in nuclear medicine. The post The Transformative Impact of Radiopharmaceuticals in Medical Imaging appeared first on Open Medscience.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Imaging Nuclear Medicine Medical 52

AuntMinnie

APRIL 13, 2023

Fusion Pharmaceuticals has secured clearance from the U.S. Read more on AuntMinnie.com Related Reading: Fusion heralds FDA tumor therapy clearance Fusion and Niowave ink $5M collaboration Fusion Pharmaceuticals to build radiopharma plant in Canada Fusion buys radiopharmaceutical from Ipsen Food and Drug Administratio.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals 52

AuntMinnie

MAY 1, 2024

NETTER-P was conducted as part of a pediatric Written Request under the Best Pharmaceuticals for Children Act, the FDA stated. The application was granted priority review and orphan drug designation. A postmarketing requirement was issued to assess the long-term safety of Lu-177 DOTATATE in adolescents.

Radiopharmaceuticals 88

Radiopharmaceuticals Pharmaceutical Radiology 88

AuntMinnie

MAY 29, 2024

The end-to-end care continuum is designed to support clinicians and promote developments for lung health in the pharmaceutical and medical device industries. will unveil its lung care continuum at the ASCO annual meeting. It features AI tools that identify, measure, manage, and monitor lung health developments.

Pharmaceutical 52

Pharmaceutical X-ray Medical Device Clinic 52

Radiology Business

APRIL 17, 2023

For one pharmaceutical company, a plan to independently source barium and iodine from North America may offer protection from global supply chain disruptions.

Pharmaceutical 66

Pharmaceutical Imaging 66

Imaging Technology

FEBRUARY 14, 2024

PanTera is committed to supporting the pharmaceutical industry by scaling up production to meet the significant global demand for targeted radiopharma-based therapeutics in the fight against cancer.”

Pharmaceutical 81

Pharmaceutical Radiopharmaceuticals Medical Clinic 81

Imaging Technology

JUNE 21, 2023

milla1cf Wed, 06/21/2023 - 19:47 June 21, 2023 — Fresenius Kabi , a leading provider of injectable medicines, announced today it has launched the diagnostic pharmaceutical agent, Sincalide for Injection, an authorized generic for Bracco Diagnostics Inc. ’s s Kinevac (Sincalide for Injection) product.

IT 86

IT Pharmaceutical Radiology X-ray 86

AuntMinnie

MARCH 5, 2024

Telix Pharmaceuticals has entered an agreement to acquire Canadian diagnostic imaging isotopes company ARTMS for $82 million. Under the agreement, Telix will take on ARTMS’ cyclotron-based isotope production platform, manufacturing plant, and stockpile of ultrapure rare metals such as zinc-68, which is irradiated to produce gallium-68.

Pharmaceutical 52

Pharmaceutical Diagnostic Imaging Diagnostic Imaging 52

AuntMinnie

JUNE 23, 2023

Radiopharmaceutical developer Actinium Pharmaceuticals is highlighting six researc. Read more on AuntMinnie.com Related Reading: Actinium, Astellas to create actinium-225 radiotherapies Zevacor signs on as manufacturing partner for Actinium

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals 52

AuntMinnie

JULY 24, 2023

Radiopharmaceutical developer Clarity Pharmaceuticals has reached 50% recruitmen.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals 52

AuntMinnie

AUGUST 31, 2023

Radiotherapy developer Actinium Pharmaceuticals will present three abstract. Read more on AuntMinnie.com Related Reading: Actinium highlights six abstracts at SNMMI 2023 Actinium, Astellas to create actinium-225 radiotherapies SNMMI 2020: PET tracer could image, treat glioblastoma Zevacor signs on as manufacturing partner for Actinium

Pharmaceutical 52

Pharmaceutical Imaging 52

AuntMinnie

JANUARY 24, 2024

TerraPower Isotopes has shipped its first samples of Actinium-225 (Ac-225) to two pharmaceutical companies to develop targeted cancer treatments in drug trials. Ac-225 is an alpha-emitting radionuclide that can be attached to a ligand that binds to cancer cells.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Radiation Oncology IT 52

Imaging Technology

JUNE 15, 2023

For pharmaceutical companies and researchers, using this tracer to better understand the mechanism of action - i.e. the effect of immunotherapies on a patient’s immune response to their cancer - could, potentially, enable them to better select patients to participate in clinical trials and bring new immunotherapies to market.

Radiopharmaceuticals 83

Radiopharmaceuticals Pharmaceutical Nuclear Medicine PET Scan 83

AuntMinnie

AUGUST 28, 2023

Read more on AuntMinnie.com Related Reading: Clarity advances dose escalation for cohort in SECuRE trial Clarity reaches 50% recruitment for SABRE trial NorthStar and Bayer reach Ac-225 supply deal NorthStar manufactures Cu-67 for Clarity Pharmaceuticals NorthStar appoints new president/CEO

Pharmaceutical 52

Pharmaceutical Clinic Medical 52

AuntMinnie

JUNE 22, 2023

from Cardinal Health FDA clears Cardinal's Lymphoseek for pediatric use Cardinal Health joins SNMMI's Value Initiative Cardinal Health taps new head of pharmaceutical unit Read more on AuntMinnie.com Related Reading: Navidea secures $7.5M

Pharmaceutical 52

Pharmaceutical IT 52

AuntMinnie

JANUARY 24, 2024

Under the agreement, EBG-USA and AbbVie will collaborate with EBG-USA’s academic and pharmaceutical partner network to validate preclinical and clinical PET ligands during an initial evaluation period. If the evaluations are favorable, EBG-USA has the option to negotiate an exclusive license agreement with AbbVie for the PET ligands.

Pharmaceutical 59

Pharmaceutical Disease Clinic Imaging 59

AuntMinnie

AUGUST 23, 2023

Telix Pharmaceuticals reported a spike in revenue for the first half of 2023. Read more on AuntMinnie.com Related Reading: Telix doses first patient in Chinese prostate cancer trial Telix to acquire Lightpoint Medical for $20M First patient dosed in phase II Telix Starburst trial Telix acquires Dedicaid for $1.2M

Pharmaceutical 52

Pharmaceutical Medical 52

AuntMinnie

SEPTEMBER 11, 2023

Read more on AuntMinnie.com Related Reading: Monrol to supply Telix with Lu-177 for renal cancer trial Monrol and MTTI ink Lu-177 supply deal Telix, Monrol reach agreement on therapeutic isotope supply Eczacıbaşı-Monrol acquires Capintec Eczacıbaşı Pharmaceuticals buys half of Monrol

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals 52

Imaging Technology

JUNE 19, 2023

President and Chief Executive Officer Dr. Scholz joined NorthStar in June 2021, as Senior Vice President and Chief Operating Officer, bringing more than 20 years of relevant experience in the pharmaceutical and life sciences industries to the Company. Frank Scholz, Ph.D., In 2022, he was promoted to President and Chief Operating Officer.

Medical 77

Medical Pharmaceutical Radiopharmaceuticals Nuclear Medicine 77

AuntMinnie

AUGUST 14, 2023

Telix Pharmaceuticals said the first patient has been dosed in a trial in Chin. Read more on AuntMinnie.com Related Reading: Telix to acquire Lightpoint Medical for $20M First patient dosed in phase II Telix Starburst trial Telix acquires Dedicaid for $1.2M

Pharmaceutical 52

Pharmaceutical Medical 52

AuntMinnie

JUNE 19, 2023

The first patient has been dosed in Telix Pharmaceuticals' carbonic anhydrase-targetin. Read more on AuntMinnie.com Related Reading: Telix acquires Dedicaid for $1.2M Telix gets FDA nod for gallium injection prep kit Telix makes two new executive appointments Telix highlights kidney cancer imaging study results Telix relocates U.S.

Pharmaceutical 52

Pharmaceutical Imaging 52

AuntMinnie

JULY 19, 2023

Read more on AuntMinnie.com Related Reading: NorthStar manufactures Cu-67 for Clarity Pharmaceuticals NorthStar appoints new president/CEO NorthStar installs accelerator at its new Wisc. NorthStar Medical Isotopes will supply Bayer with the medical radioisotope actinium-22.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Medical IT 52

AuntMinnie

JUNE 21, 2023

Telix Pharmaceuticals has entered a $20 million agreement to acquire th. Read more on AuntMinnie.com Related Reading: First patient dosed in phase II Telix Starburst trial Telix acquires Dedicaid for $1.2M

Pharmaceutical 52

Pharmaceutical Medical Imaging 52

AuntMinnie

APRIL 27, 2023

Telix Pharmaceuticals has acquired Vienna, Austria-based Dedicaid, a spin-of. Read more on AuntMinnie.com Related Reading: Telix gets FDA nod for gallium injection prep kit Telix makes two new executive appointments Telix highlights kidney cancer imaging study results Telix relocates U.S.

Pharmaceutical 52

Pharmaceutical Imaging 52

Imaging Technology

OCTOBER 11, 2023

GE HealthCare’s Pharmaceutical Diagnostics segment is a global leader in imaging agents used to support around 100 million procedures per year globally, equivalent to three patient procedures every second. SOFIE and GE HealthCare will collaborate on both the development and commercialization processes through a joint steering committee.

Healthcare 89

Healthcare Healthcare Pharmaceutical Radiopharmaceuticals 89